Approval based on data from Phase III DEPICT clinical program in type 1 diabetes
First approval of oral type 1 diabetes therapy in the EUThe SGLT2 class for use by people with type 1 diabetes is under scrutiny, but the EU has approved one, marking the first oral for type 1 diabetes in the EU.
> Read more